Related Experiment Videos
Potential therapeutic uses of N-methyl-D-aspartate antagonists in cerebral ischemia
1Department of Neurology and Neurological Sciences, Stanford University Medical Center, CA 94305.
Clinical Neuropharmacology
|June 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Comprehensive Venous Outflow Predicts Functional Outcomes in Patients with Acute Ischemic Stroke Treated by Thrombectomy.
AJNR. American journal of neuroradiology·2023
Tissue at Risk and Ischemic Core Estimation Using Deep Learning in Acute Stroke.
AJNR. American journal of neuroradiology·2021
Hypoperfusion intensity ratio correlates with angiographic collaterals in acute ischaemic stroke with M1 occlusion.
European journal of neurology·2020
Thrombectomy with Conscious Sedation Compared with General Anesthesia: A DEFUSE 3 Analysis.
AJNR. American journal of neuroradiology·2019
Low yield of clinically significant transesophageal echocardiographic findings in patients with lacunar stroke.
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Multi-Center Study of Diffusion-Weighted Imaging in Coma After Cardiac Arrest.
Neurocritical care·2015
Benzodiazepine-Sparing Alcohol Withdrawal Protocol Pilot in Postsurgical Head and Neck Cancer Patients.
Clinical neuropharmacology·2026
Retrograde Ejaculation Associated With Paliperidone Palmitate: A Case Report.
Clinical neuropharmacology·2026
Zinc-associated Copper Deficiency Myelopathy: A Case Report.
Clinical neuropharmacology·2026
Synergistic lipase inhibition by Garcinia parvifolia metabolites: a 1H NMR-based metabolomic deciphering of ligand interactions.
Metabolomics : Official journal of the Metabolomic Society·2026
Design, synthesis, and evaluation of fluorescent probes targeting DNA polymerase theta (Polθ) for inhibitor screening and cellular imaging.
European journal of medicinal chemistry·2026
Proteolysis Targeting Chimera (PROTAC) Linkerology Enhances the CDK-Degradation Selectivity Profile of a Multi-CDK Inhibitor: Discovery of Potent, Anti-Leukemic CDK9 Degraders.
ACS pharmacology & translational science·2026